Global Multiplex PCR Assays Market is expected to grow at a CAGR of XX% during the forecast period. The major factors driving the growth of this market are increasing demand for personalized medicine, growing prevalence of chronic diseases, and technological advancements in molecular diagnostics.
The global multiplex PCR assays market is segmented on the basis of type into products and services. The product segment accounted for XX% share in 2017 and is expected to grow at a CAGR of XX% during the forecast period. The service segment accounted for XX% share in 2017 and is expected to grow at a CAGR of XX%.
On the basis of application, global multiplex PCR assays market can be divided into hospitals, pharmaceutical & biotechnology companies, research institutes, and others (academic institutions). Hospitals accounted for xx% share in 2017 and are expected to grow at a CAGR xx%. Pharmaceutical & biotechnology companies accounted for xx% share in 2017 and are expected to grow at a CAGR xx%. Research institutes accounted for xx% share in 2017 and are expected to grow at a CAGR xx%. Others (academic institutions) account for xxx % share in 2017 with an anticipated growth rate xxx % over the next five years.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases are driving the growth of the Multiplex PCR Assays market.
- Increasing demand for personalized medicine is also driving the growth of the Multiplex PCR Assays market.
- Technological advancements in molecular diagnostics are also driving the growth of the Multiplex PCR Assays market.
- The increasing number of research and development activities in this field is also driving the growth of this market.
Industry Growth Insights published a new data on “Multiplex PCR Assays Market”. The research report is titled “Multiplex PCR Assays Market research by Types (Products, Services, ), By Applications (Hospitals, Pharmaceutical & Biotechnology Companies, Research Institutes, Others, ), By Players/Companies Abbott, Siemens, Roche, Agena Bioscience, BD, PerkinElmer, Luminex, QIAGEN, Agilent Technologies, Meso Scale Diagnostics, Randox Laboratories, Seegene, Olink, Illumina, Bio-Rad Laboratories, Abcam, Quanterix, ”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Multiplex PCR Assays Market Research Report
By Type
Products, Services,
By Application
Hospitals, Pharmaceutical & Biotechnology Companies, Research Institutes, Others,
By Companies
Abbott, Siemens, Roche, Agena Bioscience, BD, PerkinElmer, Luminex, QIAGEN, Agilent Technologies, Meso Scale Diagnostics, Randox Laboratories, Seegene, Olink, Illumina, Bio-Rad Laboratories, Abcam, Quanterix,
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Multiplex PCR Assays Market Report Segments:
The global Multiplex PCR Assays market is segmented on the basis of:
Types
Products, Services,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Pharmaceutical & Biotechnology Companies, Research Institutes, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Siemens
- Roche
- Agena Bioscience
- BD
- PerkinElmer
- Luminex
- QIAGEN
- Agilent Technologies
- Meso Scale Diagnostics
- Randox Laboratories
- Seegene
- Olink
- Illumina
- Bio-Rad Laboratories
- Abcam
- Quanterix
Highlights of The Multiplex PCR Assays Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Products
- Services
- By Application:
- Hospitals
- Pharmaceutical & Biotechnology Companies
- Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Multiplex PCR Assays Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Multiplex PCR assays are a type of PCR assay that allow for the simultaneous detection of multiple target sequences. Multiplex PCR assays are often used to detect multiple targets in a single reaction, or to determine the presence or absence of multiple target sequences.
Some of the key players operating in the multiplex pcr assays market are Abbott, Siemens, Roche, Agena Bioscience, BD, PerkinElmer, Luminex, QIAGEN, Agilent Technologies, Meso Scale Diagnostics, Randox Laboratories, Seegene, Olink, Illumina, Bio-Rad Laboratories, Abcam, Quanterix.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Multiplex PCR Assays Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Multiplex PCR Assays Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Multiplex PCR Assays Market - Supply Chain
4.5. Global Multiplex PCR Assays Market Forecast
4.5.1. Multiplex PCR Assays Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Multiplex PCR Assays Market Size (000 Units) and Y-o-Y Growth
4.5.3. Multiplex PCR Assays Market Absolute $ Opportunity
5. Global Multiplex PCR Assays Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Multiplex PCR Assays Market Size and Volume Forecast by Type
5.3.1. Products
5.3.2. Services
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Multiplex PCR Assays Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Multiplex PCR Assays Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Pharmaceutical & Biotechnology Companies
6.3.3. Research Institutes
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Multiplex PCR Assays Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Multiplex PCR Assays Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Multiplex PCR Assays Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Multiplex PCR Assays Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Multiplex PCR Assays Demand Share Forecast, 2019-2026
9. North America Multiplex PCR Assays Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Multiplex PCR Assays Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Multiplex PCR Assays Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Pharmaceutical & Biotechnology Companies
9.4.3. Research Institutes
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Multiplex PCR Assays Market Size and Volume Forecast by Type
9.7.1. Products
9.7.2. Services
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Multiplex PCR Assays Demand Share Forecast, 2019-2026
10. Latin America Multiplex PCR Assays Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Multiplex PCR Assays Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Multiplex PCR Assays Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Pharmaceutical & Biotechnology Companies
10.4.3. Research Institutes
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Multiplex PCR Assays Market Size and Volume Forecast by Type
10.7.1. Products
10.7.2. Services
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Multiplex PCR Assays Demand Share Forecast, 2019-2026
11. Europe Multiplex PCR Assays Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Multiplex PCR Assays Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Multiplex PCR Assays Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Pharmaceutical & Biotechnology Companies
11.4.3. Research Institutes
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Multiplex PCR Assays Market Size and Volume Forecast by Type
11.7.1. Products
11.7.2. Services
11.8. Basis Point Share (BPS) Analysis by Type 11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Multiplex PCR Assays Demand Share, 2019-2026
12. Asia Pacific Multiplex PCR Assays Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Multiplex PCR Assays Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Multiplex PCR Assays Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Pharmaceutical & Biotechnology Companies
12.4.3. Research Institutes
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Multiplex PCR Assays Market Size and Volume Forecast by Type
12.7.1. Products
12.7.2. Services
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Multiplex PCR Assays Demand Share, 2019-2026
13. Middle East & Africa Multiplex PCR Assays Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Multiplex PCR Assays Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Multiplex PCR Assays Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Pharmaceutical & Biotechnology Companies
13.4.3. Research Institutes
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Multiplex PCR Assays Market Size and Volume Forecast by Type
13.7.1. Products
13.7.2. Services
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Multiplex PCR Assays Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Multiplex PCR Assays Market: Market Share Analysis
14.2. Multiplex PCR Assays Distributors and Customers
14.3. Multiplex PCR Assays Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Siemens
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Roche
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Agena Bioscience
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. BD
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. PerkinElmer
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Luminex
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. QIAGEN
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Agilent Technologies
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Meso Scale Diagnostics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Randox Laboratories
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Seegene
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Olink
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Illumina
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Bio-Rad Laboratories
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Abcam
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Quanterix
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18.
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
